Topic
Prostate Cancer
66 Podcasts • 2 Courses on BackTable
Hear how experienced physicians manage Prostate Cancer on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering diagnosis, clinical decision-making, and treatments. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 325 • 25 Aug 2026
Navigating the PSA Maze in Urology
Is an elevated prostate-specific antigen (PSA) the beginning or the end of the prostate cancer workup? On this episode of BackTable Urology, Dr. Ruchika Talwar interviews Dr. Tarik Benidir to explore the “PSA problem,” explaining why PSA is biologically useful but clinically imprecise, often leading to false positives, unnecessary biopsies, and detection of indolent disease. They discuss a rational, patient-centered approach to elevated PSA, including when to repeat the test, how to interpret results in the context of age, race, family history, and prostate size, and the use of PSA density and age-adjusted norms instead of rigid cutoffs.
This podcast is supported by
More on Prostate Cancer
Loading recent podcasts…
Urology # 325
Aug 24, 2026
with Dr. Tarik Benidir, Dr. Ruchika Talwar
Is an elevated prostate-specific antigen (PSA) the beginning or the end of the prostate cancer workup? On this episode...
1,200+ listens
Urology # 317
Jul 16, 2026
with Dr. George R. Schade, Dr. Tiwa Akinsola
Can focal therapy truly “thread the needle” between active surveillance and radical prostate cancer treatment? In this...
1,500+ listens
Urology # 314
Jul 6, 2026
with Dr. Rana McKay, Dr. Emmanuel Antonarakis, Dr. Alan Tan
With multiple clinical trials evaluating PARP inhibitor combinations, how do clinicians determine the best approach for...
1,000+ listens
Urology # 307
Jun 8, 2026
with Dr. Tanya Dorff, Dr. Evan Yu, Dr. Alan Tan
Can you really treat prostate cancer effectively without knowing the genetics? In this episode of BackTable Urology,...
1,000+ listens
Tumor Board # 76
Aug 10, 2026
with Dr. Alan Tan, Dr. Katy Beckermann
Is GU oncology entering a new era of early intensification and precision therapy? On this episode of the BackTable...
Tumor Board # 71
Jul 6, 2026
with Dr. Rana McKay, Dr. Emmanuel Antonarakis, Dr. Alan Tan
With multiple clinical trials evaluating PARP inhibitor combinations, how do clinicians determine the best approach for...
Urology # 313
Jun 29, 2026
with Dr. Kirsten Greene, Dr. Ruchika Talwar
Is pelvic lymph node dissection still necessary in the era of PSMA PET imaging? In this episode of BackTable Urology,...
1,400+ listens
Urology # 303
May 18, 2026
with Dr. Neeraj Agarwal, Dr. Arun Azad, Dr. Alan Tan
Keeping patients on PARP inhibitors long enough to see real benefit often comes down to proactive side effect...
1,300+ listens
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.